Infection Control

Wednesday 23rd May 2012, Royal College of Surgeons - London, 09:00 - 16:35

Infection Control and Prevention: Clean, Safe, Quality Care

Overview

According to the National Institute for Health and Clinical Excellence (NICE), the most up-to-date figures, from 2009, reveal that 77 trusts in England reported 831 outbreaks of norovirus, the majority of which led to some form of ward closure. In 2009/10, there were nearly 2,000 reported incidences of MRSA and over 25,000 reports of CDI at a cost to the NHS of around £260 million. The Department of Health has introduced a number of measures that have been successful in helping the NHS reduce rates of MRSA bloodstream infections and CDI, but HCAI's remain a significant financial burden for the NHS and as a result, infection prevention and control continues to be a key priority for the NHS.

The Department of Health in its recent White Paper, Equity and Excellence: Liberating the NHS, published July 2010, put increased safety and infection control at the heart of its proposals, emphasising that the NHS should refuse to tolerate unsafe and substandard care. Furthermore, The NHS Outcomes Framework 2011/12, published December 2010, outlines treating and caring for people in a safe environment and protecting them from avoidable harm as a key objective.

To support the NHS Commissioning Board, GP commissioning consortia and those providing NHS care to deliver the outcomes set out in this NHS Outcomes Framework, NICE published its quality improvement guide on the prevention and control of healthcare associated infections in secondary care settings on the 9 November 2011. Produced in partnership with the Health Protection Agency (HPA), the guide identifies the organisational characteristics, arrangements and practices that describe excellence in care and practice to prevent and control HCAI's. The guide consists of eleven quality improvement statements describing a level of excellence in infection prevention and control at a management or organisational level.

Agenda

HCAIs cause unnecessary pain and suffering to patients and cost the NHS approximately £1billion per year. This timely forum will provide delegates with the opportunity to hear the latest government policy and measures on preventing and controlling healthcare associated infections, whilst also hearing from leading practitioners on delivering clean and safe care to patients and tackling infections through innovation, technology and design.

09:00	Coffee and Registration
09:40	Chair’s Welcome Address Paul Unsworth, Area Director London, NHS Institute for Innovation and Improvement (CONFIRMED)
09:45	Morning Keynote: Tackling Healthcare-Associated Infections – Ensuring Patient Safety National strategic support and guidance for continuous improvement and elimination of avoidable healthcare associated infections The journey towards zero tolerance The development of composite HAI indicators The future of MRSA screening Helping fight infections through technology Professor Mike Sharland, Chair of the Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections, Department of Health & Professor of Paediatric Infectious Diseases, St George's Hospital (CONFIRMED)
10:05	NICE and HPA Quality Improvement Guide: Prevention and Control of Healthcare-Associated Infections Prevention and control of healthcare associated infections (HCAI's) in secondary care settings Identifying the organisational characteristics, arrangements and practices that describe excellence in care and practice to prevent and control HCAI's Developing a culture of continuous quality improvement Using information to drive improvement Multi-agency working to reduce HCAI's Builds on the Code of Practice - improving patient safety and outcomes by improving quality Supporting the NHS Commissioning Board, GP commissioning consortia and those providing NHS care to deliver the outcomes set out in this NHS Outcomes Framework Practical examples of best practice Dr Catherine Swann, Associate Director, Centre for Public Health Excellence (CPHE), National Institute for Health and Clinical Excellence (NICE) (CONFIRMED)
10:25	The Future Landscape: Minimising the Threat Achieving a further 29% reduction in MRSA bloodstream infections and a further 18% reduction in Clostridium difficile infections by April 2013 The role of HPA in infection control and prevention Improving infection control and prevention in care homes Developing a skilled and knowledgeable workforce that has the capacity and capability to deliver continuous quality improvement Outcomes of the pilots Dr Susan Hopkins, Healthcare Epidemiologist, Health Protection Agency (CONFIRMED)
10:45	Sponsor Session: Ethicon Speaker to be confirmed
11:05	Questions and Answers Session
11:25	Coffee Break and Networking
11:45	Delivering Clean, Safe Quality Care with Privacy and Dignity Improving perceptions of NHS hospital safety Focusing on high standards of hygiene and cleanliness and achieving year on year reductions in Methicillin Resistant Staphylocuccus Aureus (MRSA) Improving perceptions of NHS hospital safety The importance of a clean patient environment Promoting a zero-tolerance approach to preventable healthcare associated infections Engaging and involving patients in sustaining progress and continuous improvement Role of nursing in infection prevention Annette Jeanes, Consultant Nurse and Director of Infection Prevention and Control, University College London Hospitals NHS Foundation Trust (CONFIRMED)
12:05	Case Study: Using Technology to Help Fight Infection Identifying which new technologies provide the best value and will have the most impact Building a strong working relationship between clinical staff & IT Ensuring a commitment from the executive and senior management teams Experiences from the HCAI Technology Innovation Programme Putting the infrastructure in place to make large scale savings through technology Evaluating HCAI technologies that show promise Erika Grobler, Deputy Director of Infection Prevention and Control, & Dr Jack Barker, Clinical Director for IT, King's College Foundation Hospital NHS Trust (CONFIRMED)
12:25	Clostridium difficile: Reducing the Threat of Environmental Contamination Requirements of an environmental cleaning and decontamination programme Reviewing evidence of activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination Implementation of an organisation wide hydrogen peroxide decontamination programme to discuss the practical elements involved Sustaining the decontamination programme 6 years on Natalie Vaughan, Clinical Lead Infection Prevention and Control, Nottingham University Hospitals NHS Trust (CONFIRMED)
12:45	Questions and Answers Session
13:00	Lunch Break and Networking
14:00	Inspection of the Prevention and Control of Infections: Ensuring Quality of Care For All Meeting the new regulation on HCAI's Improving communication between hospitals and care homes to prevent infections Priorities for quality and safety in healthcare provision from a regulator’s point of view NHS progress on infection control Improving patient safety through case note reviews Effectively reporting errors and incidents to meet CQC requirements Monitoring and inspecting non-acute services Meeting the Code of Practice and Hygiene Code Louise Dineley, Head of Regulatory Risk, Care Quality Commission (CONFIRMED)
14:20	Developing a Whole System Approach To Improving Infection Control and Prevention in Care Homes Improving infection control and prevention in care homes Providing adequate infection control training for new staff Working with hospitals to ensure a whole-system approach to tackling avoidable healthcare associated infections The use of antibiotics in care homes Overcoming common audit problems Results achieved and best practice Anita Watson, Lead Nurse Infection Prevention and Control, NHS North Lancashire (CONFIRMED)
14:45	Improving the Management of C. diff Infection – Tackling the Burden of Recurrence Clostridium difficile infection (CDI) is the most important cause of hospital-acquired diarrhoea and the 2012/13 NHS Operating Framework highlights the continuing “zero tolerance approach” to reducing incidence rates across the UK. The NHS is being asked to reduce the number of infections of C. difficile in 2012-13 by a further 18% compared to the previous year. A significant limitation of currently available antibiotics used to treat CDI is the high rate of disease recurrence. Recurrent CDI can have a profound effect on patient welfare, especially in patients who develop multiple recurrences, and also impacts upon health service expenditure and infection control practices. A new antibiotic being launched by Astellas in 2012 is the first new antibiotic to be licensed for the treatment of CDI since the 1950s. Highlight the importance of better identification and management of patients at risk of recurrence Dr. Alan McDougall, Medical & Regulatory Affairs Director, Astellas Pharma Ltd (UK) (CONFIRMED)
15:05	Questions and Answers Session
15:20	Coffee Break and Networking
15:40	Designing out Bugs How can the effective use of design improve patient safety in a whole system context Developing a design-led approach to infection control Building an effective NHS knowledge base Working in partnership with industry to help ensure that the design of healthcare products increasingly focuses on delivering safer patient care Speeding up the development and adoption of new and novel technologies to help combat HCAI Ed Matthews, Head of Healthcare & Patient Safety Lab, Helen Hamlyn Centre for Design, Royal College of Art (CONFIRMED)
16:00	Case Study: Using Data and Information For Improvement Improving efficiency, reducing errors and enhancing patient outcomes through information Diagnosing where the problems are Supporting a business case for an improvement programme Altering behaviour by presenting a case for change Demonstrating where progress is being made Evaluating and comparing performance Using information to make effective decisions about appropriate infection prevention and control and care quality improvement activities Vicki Dixon, HCAI Programme Manager, South East Coast Quality Observatory (CONFIRMED)
16:20	Questions and Answers Session
16:35	Chair's Summary and Close

*programme subject to change without notice

Contributors:

Audience

Delegates attending this forum will include clinical directors, medical directors, directors of infection prevention and control, HCAI managers, infection control advisors, specialist nurses, estate and facilities managers, heads of innovation, leads in acute care, heads of patient safety and will be drawn from the NHS, care home providers, emergency services, private hospitals, central government, academia and the third sector.